Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.03.062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Nobuyuki Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan. Hauptthemen laut MEDLINE: Hematinics, Prolyl-Hydroxylase Inhibitors, Kidney Transplantation, Anemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
- Department of Urology, Fukuoka University Faculty of Medicine, Fukuoka, Japan. Electronic address: nhaga@fukuoka-u.ac.jp.
Zitieren
APA
Nakamura, N., Aso, S., Nakagawa, C., Tachibana, M., Fujikawa, A., Tsubouchi, K., Gunge, N., Miyazaki, T., Okabe, Y., Matsuzaki, H., Matsuoka, H., & Haga, N. (2023). Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.03.062
Vancouver
Nakamura N, Aso S, Nakagawa C, Tachibana M, Fujikawa A, Tsubouchi K, et al. Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.03.062
BibTeX
@article{Nakamura2023,
author = {Nakamura, Nobuyuki and Aso, Shintaro and Nakagawa, Chizuru and Tachibana, Masahiro and Fujikawa, Aiko and Tsubouchi, Kazuna and Gunge, Naotaka and Miyazaki, Takeshi and Okabe, Yu and Matsuzaki, Hiroshi and Matsuoka, Hirofumi and Haga, Nobuhiro},
title = {Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Therapy for Anemia in Renal Transplantation Patients by Prior Erythropoiesis Stimulating Agent Use},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.03.062}
}
EUVIMED